Guggenheim Capital LLC Exact Sciences Corp Transaction History

Guggenheim Capital LLC

  • $12 Billion
  • Q4 2024

A detailed history of Guggenheim Capital LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Guggenheim Capital LLC holds 28,797 shares of EXAS stock, worth $1.32 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
28,797
Previous 33,256 13.41%
Holding current value
$1.32 Million
Previous $2.26 Million 28.53%
% of portfolio
0.01%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$49.33 - $71.97 $219,962 - $320,914
-4,459 Reduced 13.41%
28,797 $1.62 Million
Q3 2024

Nov 13, 2024
SELL
$42.43 - $70.83 $348,435 - $581,655
-8,212 Reduced 19.8%
33,256 $2.26 Million
Q2 2024

Aug 14, 2024
BUY
$41.33 - $74.26 $248,517 - $446,525
6,013 Added 16.96%
41,468 $1.75 Million
Q1 2024

May 14, 2024
BUY
$56.27 - $73.77 $144,445 - $189,367
2,567 Added 7.81%
35,455 $2.45 Million
Q4 2023

Feb 14, 2024
SELL
$59.06 - $75.72 $45,712 - $58,607
-774 Reduced 2.3%
32,888 $2.43 Million
Q3 2023

Nov 14, 2023
BUY
$65.94 - $99.04 $104,646 - $157,176
1,587 Added 4.95%
33,662 $2.3 Million
Q2 2023

Aug 11, 2023
SELL
$62.68 - $95.05 $475,302 - $720,764
-7,583 Reduced 19.12%
32,075 $3.01 Million
Q1 2023

May 10, 2023
SELL
$47.19 - $70.77 $657,970 - $986,746
-13,943 Reduced 26.01%
39,658 $2.69 Million
Q4 2022

Feb 14, 2023
SELL
$30.35 - $53.15 $273,150 - $478,350
-9,000 Reduced 14.38%
53,601 $2.65 Million
Q3 2022

Nov 14, 2022
SELL
$31.97 - $49.37 $393,167 - $607,152
-12,298 Reduced 16.42%
62,601 $2.03 Million
Q2 2022

Aug 15, 2022
BUY
$35.61 - $76.23 $365,216 - $781,814
10,256 Added 15.87%
74,899 $2.95 Million
Q1 2022

May 16, 2022
SELL
$57.56 - $82.54 $88,354 - $126,698
-1,535 Reduced 2.32%
64,643 $4.52 Million
Q4 2021

Feb 14, 2022
BUY
$72.5 - $100.68 $448,340 - $622,605
6,184 Added 10.31%
66,178 $5.15 Million
Q3 2021

Nov 15, 2021
BUY
$90.24 - $124.05 $367,186 - $504,759
4,069 Added 7.28%
59,994 $5.73 Million
Q2 2021

Aug 13, 2021
BUY
$93.66 - $139.27 $31,188 - $46,376
333 Added 0.6%
55,925 $6.95 Million
Q1 2021

May 13, 2021
BUY
$116.57 - $155.01 $314,855 - $418,682
2,701 Added 5.11%
55,592 $7.33 Million
Q4 2020

Feb 16, 2021
SELL
$99.61 - $142.12 $1.3 Million - $1.86 Million
-13,080 Reduced 19.83%
52,891 $7.01 Million
Q3 2020

Nov 13, 2020
SELL
$72.92 - $102.01 $445,832 - $623,689
-6,114 Reduced 8.48%
65,971 $6.73 Million
Q2 2020

Aug 14, 2020
BUY
$55.75 - $92.75 $1.02 Million - $1.7 Million
18,300 Added 34.02%
72,085 $6.27 Million
Q1 2020

Jun 02, 2020
SELL
$37.9 - $104.44 $380,440 - $1.05 Million
-10,038 Reduced 15.73%
53,785 $3.12 Million
Q4 2019

Feb 14, 2020
BUY
$77.66 - $99.74 $1.13 Million - $1.45 Million
14,554 Added 29.54%
63,823 $5.9 Million
Q3 2019

Nov 14, 2019
SELL
$90.37 - $122.49 $130,946 - $177,488
-1,449 Reduced 2.86%
49,269 $4.45 Million
Q2 2019

Aug 14, 2019
SELL
$89.51 - $118.04 $994,366 - $1.31 Million
-11,109 Reduced 17.97%
50,718 $5.99 Million
Q1 2019

May 15, 2019
SELL
$61.98 - $96.5 $583,727 - $908,837
-9,418 Reduced 13.22%
61,827 $5.36 Million
Q4 2018

Feb 14, 2019
SELL
$56.04 - $82.66 $179,159 - $264,264
-3,197 Reduced 4.29%
71,245 $4.5 Million
Q3 2018

Nov 14, 2018
SELL
$48.29 - $80.6 $231,792 - $386,880
-4,800 Reduced 6.06%
74,442 $5.88 Million
Q2 2018

Aug 14, 2018
SELL
$37.84 - $69.96 $1.09 Million - $2.01 Million
-28,765 Reduced 26.63%
79,242 $4.74 Million
Q1 2018

May 15, 2018
SELL
$39.82 - $57.53 $6,132 - $8,859
-154 Reduced 0.14%
108,007 $4.36 Million
Q4 2017

Feb 14, 2018
SELL
$46.49 - $60.51 $1.15 Million - $1.5 Million
-24,782 Reduced 18.64%
108,161 $5.68 Million
Q3 2017

Nov 14, 2017
BUY
$37.05 - $47.12 $4.93 Million - $6.26 Million
132,943
132,943 $6.27 Million

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
164M
Call Options Held
4.25M
Put Options Held
1.89M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.09B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email